KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for Bausch Health Companies (BHC) over the last 17 years, with Q3 2025 value amounting to $5.0 million.

  • Bausch Health Companies' Gains from Investment Securities changed 0.0% to $5.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $27.0 million, marking a year-over-year increase of 1250.0%. This contributed to the annual value of $26.0 million for FY2024, which is 833.33% up from last year.
  • As of Q3 2025, Bausch Health Companies' Gains from Investment Securities stood at $5.0 million, which was down 0.0% from $3.0 million recorded in Q2 2025.
  • Bausch Health Companies' 5-year Gains from Investment Securities high stood at $41.0 million for Q1 2021, and its period low was $1.0 million during Q3 2022.
  • Over the past 5 years, Bausch Health Companies' median Gains from Investment Securities value was $4.0 million (recorded in 2021), while the average stood at $8.3 million.
  • As far as peak fluctuations go, Bausch Health Companies' Gains from Investment Securities tumbled by 7500.0% in 2022, and later surged by 70000.0% in 2023.
  • Quarter analysis of 5 years shows Bausch Health Companies' Gains from Investment Securities stood at $4.0 million in 2021, then plummeted by 75.0% to $1.0 million in 2022, then changed by 0.0% to $1.0 million in 2023, then soared by 200.0% to $3.0 million in 2024, then skyrocketed by 66.67% to $5.0 million in 2025.
  • Its last three reported values are $5.0 million in Q3 2025, $3.0 million for Q2 2025, and $16.0 million during Q1 2025.